Spending-bill provision won't protect biotech firms like critics say

04/9/2013 | Bloomberg

The hysteria over a biotech crop provision signed into law last month has no basis because there's no truth to critics' claims about the law, Bloomberg View columnist Ramesh Ponnuru writes. The law's real impact is modest, and it would permit farmers to continue using products that are safe in case of frivolous lawsuits, Ponnuru writes.

View Full Article in:

Bloomberg

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA
Diagnostic Technician
Roche
Marlborough, MA
Test Technician
Roche
Marlborough, MA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
Ridgefield, CT